{"schema_version":"secwatch.filing_event.v1","accession":"0001933414-25-000107","form_type":"8-K","ticker":"MLYS","cik":"0001933414","company_name":"Mineralys Therapeutics, Inc.","filed_at":"2025-09-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.637491+00:00","generated_at":"2026-05-17T08:59:34.158695+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Mineralys Therapeutics terminates ATM prospectus supplement, halts sales until new filing","bullets":["Delivered written notice to BofA Securities and Evercore terminating prospectus supplement dated April 11, 2024.","No further sales of common stock under the Sales Agreement will occur until a new prospectus supplement is filed.","The underlying ATM Equity Offering Sales Agreement (March 21, 2024) remains in full force and effect."],"urls":{"canonical":"https://secwatch.observer/filing/0001933414-25-000107","json":"https://secwatch.observer/filing/0001933414-25-000107.json","markdown":"https://secwatch.observer/filing/0001933414-25-000107.md","text":"https://secwatch.observer/filing/0001933414-25-000107.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1933414/000193341425000107/0001933414-25-000107-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1933414/000193341425000107/mlys-20250902.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T08:59:34.158695+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}